Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avonex was produced by Biogen Idec.

MS treatment hopes

Clinicians may recommend one of three interferons (Biogen Idec's Avonex or EMD Serono/Pfizer's Rebif, which are both formulations of interferon ß-1a, or Bayer's Betaseron, an interferon ... which will both assess relapse rates, and TRANSFORMS (in

The PM Society Advertising Awards 2008

London. Highly commended: Avonex by Seven Stones for Biogen Idec. Winner: Duac. ... AstraZeneca. Highly commended: Avonex by Seven Stones for Biogen Idec. Winner: Gout Awareness.

Pharma news in brief

15, 500) per patient a year. Tysabri was withdrawn from the market at the beginning of 2005, after two patients taking it in combination with another Biogen MS drug, Avonex, developed

Pharma news in brief

combined with Avonex developed fatal brain conditions, its shares took another nose dive on reports in the Boston Globe newspaper that another patient (on monotherapy) had contracted a deadly disease.

Biogen reveals strategic updates

Specifically, the company expects its growth to be driven by the continued strong sales of multiple sclerosis (MS) treatment, Avonex (Interferon beta-1a).

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...
PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...